Division of Cardiology, Saint Antoine University Hospital
Paris, 75012, France
Location status: Recruiting
Location contact
Franck Boccara, MD, PhD
CONTACT
Mabel Nuernberg, MPH, MA
CONTACT
NCT Number: NCT02453919
The REgister of cardiovascular COmplications among people living with HIV (RECOVIH) is a single hospital registry of adults living with HIV, with one or more other cardiovascular risk factor, who undergo cardiac examination at the Cardiac Center of the Saint Antoine Hospital.
RECOVIH is an observational and prospective, monocentric (institutional) registry, with anonymized cardiac, biochemical and associated data collection.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Paris, 75012, France
Location status: Recruiting
Franck Boccara, MD, PhD
CONTACT
Mabel Nuernberg, MPH, MA
CONTACT
This hospital-based cardiac registry maintains data from all non-opposing adults living with HIV, with one or more other cardiac risk factor, who undergo complete cardiac examination at the Cardiac Center at the Saint Antoine Hospital.
RECOVIH registry:
The focus of this hospital-based cardiac registry is on clinical care, particularly on risk stratification, of adults living with HIV.
The register was designed to evaluate echocardiographic, coronarographic, and blood pressure abnormalities among people living with HIV (PLWH).
The primary goal of this single hospital registry is the improvement of patient care, especially risk stratification, by medical audit-type evaluation of cardiac tests and outcomes.
RECOVIH data and research:
Cardiac, biochemical, and associated data collected by this single hospital registry are also used as a source of data for some types of research. This research is particularly timely and relevant as currently little scientific evidence exists describing optimal cardiac care, and risk stratification, for adults living with HIV.
The primary goal of research using RECOVIH data is the quantification of morphologic and functional cardiac abnormalities and blood pressure abnormalities.
The secondary research goal is the identification and description of key aspects of the relationship between HIV, cardiovascular diseases (CVD), and CVD risk factors. Exploration of this complex relationship may help identify and describe the impact of chronic HIV related infection and inflammation, antiretroviral use (ARV), and individual health risks on the development and course of morphologic and functional cardiac abnormalities and blood pressure levels.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 20 years
Cardiovascular mortality as classified using the 10th revision of the International Classification of Diseases (cardiovascular diagnosis codes I 00-I 99).
Time frame: 20 years
Parameters concerning - left ventricular dysfunction both systolic and diastolic, valvulopathies, pulmonary pressure, pericardial involvement under cross-sectional echocardiography and tissue Doppler imaging.
Time frame: 20 years
Parameters of ischemia tests including - exercise tolerance test, and stress-echocardiography under dobutamine or exercise.
Time frame: 20 years
Parameters from - ambulatory blood pressure monitoring over 24 hours using a Pressure Holter.
Contact information is provided by the study sponsor or research team.
Franck Boccara, MD, PhD
CONTACT
Mabel Nuernberg, MPH
CONTACT
Saint Antoine University Hospital
Other
Acronym: RECOVIH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06001814
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Boston, Massachusetts, United States
View Trial DetailsNCT04725617
Behavior, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05642858
Acquired Immunodeficiency Syndrome, Arterial Occlusive Diseases
San Francisco, California, United States
View Trial DetailsNCT02344290
COVID-19, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial Details